gyn onc at asco 2022: randomized phase iii trial on trabectedin in recurrent ovarian cancer
Published 2 years ago • 342 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
5:06
asco22 gynecologic oncology: relacorilant combined with nab-paclitaxel in recurrent ovarian cancer
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
0:46
gynecologic oncology at asco 2022: subgroup analysis of keynote-826
-
3:50
gynecologic oncology at asco 2022: tv pembro in first-line recurrent or metastatic cervical cancer
-
0:53
gynecologic oncology at asco 2018: ovarian cancer, jcog0602, onda
-
7:46
expert report on novelties in the management of gynaecological malignancies from asco 2022
-
1:29
gyn onc at asco 2015: angeles alvarez-secord, md, on ovarian cancer trials
-
3:11
gynecologic cancer studies: what to look for at asco 2022
-
2:09
gynecologic oncology research at asco 2017: ovarian cancer surgery trials
-
31:36
icaho20 - asco direct™ highlights - gynecological oncology session - dr. elise simons
-
50:02
recurrent ovarian cancer (2022)
-
43:57
secondary cytoreductive surgery in ovarian cancer
-
21:18
surgical advances in ovarian cancer: what to watch
-
1:48:38
ovarian cancer: what you need to know
-
48:02
ovarian cancer: what's new?
-
5:53
current treatment standards for primary ovarian cancer
-
1:18
dr. thigpen on comparing treatments in ovarian cancer
-
0:45
gynecologic oncology: signs and symptoms of ovarian cancer